Apr 23, 2026 3-5pm ET
Thursday on The Robert Scott Bell Show:
Hour 1
Special Guest: Jonathan Emord
For the past 37 years, Jonathan W. Emord has litigated against the federal bureaucracy, winning over and over again. Ron Paul calls Jonathan “an expert in constitutional theory and history” and “an expert litigator with a long string of legal victories over the federal bureaucracy.” George Noory calls him “a Knight in Shining Armor” and “a warrior out to save our rights.” Congressmen Dan Burton and John Doolittle describe him as “an intellectual warrior for the rights and freedoms of people in America.” Jonathan has a unique, detailed knowledge of the federal bureaucracy, the deep state. He knows how to defeat it. Jonathan graduated from the University of Illinois (BA, political science and history, 1982) and DePaul University College of Law (JD, 1985). He served as an attorney in the Federal Communications Commission during the Reagan administration. A leading constitutional law and litigation expert, he is the author of five critically acclaimed books. He has won more cases against the Food and Drug Administration in federal court than any other attorney in American history, earning him the nickname “FDA Dragon Slayer.” He is a columnist for Townhall.com, PJ Media.com, Americangreatness.com, and the U.S.A. Today Magazine. He frequently appears on national radio and television programs. He is married to Sheryl Emord, and they have two children, twins Justice and Angelica. They reside in Clifton, Virginia.
The Window for Change Is Open — Don’t Sit This One Out The current political and cultural moment represents a rare and possibly short-lived window of opportunity to enact meaningful, lasting reforms in health policy, food systems, environmental protections, and regulatory frameworks that prioritize prevention, individual liberty, and root-cause solutions over the entrenched pharmaceutical and industrial models that have driven the chronic disease epidemic, and failing to act decisively now risks allowing the old guard of corporate influence and bureaucratic inertia to reassert control once public attention shifts or midterm political dynamics change. The Alliance for Natural Health USA emphasizes that the convergence of growing public awareness of ultra-processed foods, environmental toxins, vaccine safety concerns, and the failures of the sick-care model, combined with high-level appointments and executive actions aligned with the Make America Healthy Again (MAHA) agenda, has created unprecedented momentum for systemic change that may not come again for decades. Key opportunities include modernizing outdated legal definitions of “food” and “drug” to protect truthful information about natural health approaches, removing barriers to access for non-pharmaceutical interventions, ensuring fair reimbursement for preventive and integrative care, reducing regulatory capture at agencies like the FDA and EPA, and restoring parental and individual rights in medical decision-making. The statement warns that powerful special interests — pharmaceutical companies, processed food manufacturers, and entrenched bureaucrats — are already mobilizing to block or dilute these reforms through lobbying, legal challenges, media narratives, and bureaucratic resistance, making citizen engagement essential to keep the window open. It urges individuals to contact lawmakers, support aligned organizations, share evidence-based information, and participate in grassroots advocacy to build pressure for concrete legislative and regulatory action rather than symbolic gestures. The piece stresses that health freedom and true public health progress depend on sustained public demand for transparency, accountability, and a shift from managing chronic illness to building genuine health through nutrition, toxin reduction, and lifestyle medicine. The overall message is one of urgent optimism: the current alignment of political will, public awakening, and policy openings provides a genuine chance to reverse decades of decline, but this window will not remain open indefinitely, and passive observation or cynicism could allow the opportunity to slip away, leaving future generations to inherit a sicker, more regulated, and less free society.
GRAS Reform on the Horizon: What We Know and What We Don’t The “Generally Recognized as Safe” (GRAS) loophole, which allows food manufacturers to self-determine that new additives, chemicals, or ingredients are safe without mandatory FDA review or public disclosure, is facing potential reform as part of broader efforts to restore transparency and accountability in the food supply, though the exact scope, timeline, and effectiveness of any changes remain uncertain amid competing industry and consumer interests. Under the current GRAS system, established in 1958 and expanded through FDA guidance in 1997 and 2016, companies can convene their own experts (often with financial ties to the industry) to declare a substance GRAS, bypassing the more rigorous food additive petition process that requires safety data submission and FDA approval. This self-affirmation route has allowed thousands of substances — including novel emulsifiers, flavorings, preservatives, and processing aids — to enter the food supply with minimal oversight, contributing to the proliferation of ultra-processed foods and raising concerns about long-term cumulative effects, synergistic toxicities, and impacts on vulnerable populations such as children and pregnant women. The Alliance for Natural Health USA notes that recent discussions within the Make America Healthy Again (MAHA) framework and congressional interest in food additive safety have placed GRAS reform on the agenda, with proposals ranging from mandatory FDA notification and review of GRAS determinations, public disclosure of safety data, independent expert panels, and stricter conflict-of-interest rules to outright elimination or major overhaul of the self-affirmation pathway. While some industry groups argue that the current system is efficient and that most GRAS substances have a long history of safe use, critics contend that the lack of independent verification has enabled problematic additives to remain on the market and that the FDA’s limited resources and historical deference to industry have undermined consumer protection. The article highlights that meaningful reform would require congressional action or strong executive leadership to close loopholes, increase transparency, and shift the burden of proof back toward rigorous safety demonstration, but warns that without sustained public pressure and vigilance, any changes could be watered down or delayed by powerful food industry lobbying. The piece calls on readers to stay informed, contact lawmakers, and support organizations working on food additive reform to ensure that any GRAS overhaul genuinely protects public health rather than preserving the status quo under a new name.
Environmental Working Group Sues EPA Over Glyphosate in Oats, Citing Risk to Children’s Health The Environmental Working Group (EWG) has filed a lawsuit in the Ninth Circuit Court of Appeals against the U.S. Environmental Protection Agency (EPA), arguing that the agency’s approval of glyphosate residues on oats and other grains at tolerance levels as high as 30 parts per million violates the Food Quality Protection Act’s mandate to protect infants and children with an extra tenfold safety margin, given their higher food intake per body weight, developing organ systems, and greater vulnerability to pesticide toxicity. EWG’s independent testing has repeatedly detected glyphosate in popular oat-based breakfast cereals, granola bars, and other products marketed to children, often at levels that raise concerns about cumulative exposure when combined with other dietary sources. The lawsuit contends that the EPA failed to conduct an adequate cumulative risk assessment that properly accounts for children’s unique susceptibilities, the herbicide’s classification as a probable human carcinogen by the International Agency for Research on Cancer, its endocrine-disrupting potential, and emerging evidence of harm to the developing nervous system and gut microbiome. Glyphosate is heavily used as a desiccant on oats and wheat just before harvest, leading to higher residues in finished foods compared to crops where it is applied only for weed control. The legal action seeks to compel the EPA to lower or revoke the current tolerances for glyphosate on oats and other grains until a comprehensive, child-protective risk assessment is completed using the best available independent science rather than industry-submitted data. The article notes that this lawsuit is part of a broader effort to challenge EPA pesticide tolerances that critics say prioritize agricultural convenience and industry interests over public health, especially for the most vulnerable populations. EWG and allied groups argue that safer farming practices and organic alternatives already demonstrate that high-yield oat production is possible without glyphosate, making continued allowance of these residues unnecessary and risky for children. The piece frames the legal challenge as a necessary step to force regulatory accountability and protect children from chronic low-level exposure to one of the world’s most controversial herbicides.
Dr. Erica Schwartz and the Only Question That Matters The nomination of Dr. Erica Schwartz to a senior leadership role at the CDC has sparked intense debate within the Make America Healthy Again (MAHA) community, with critics arguing that her past support for COVID-19 vaccine mandates, mask policies, and conventional public health frameworks during her time as a senior officer in the U.S. Coast Guard and at the Department of Homeland Security raises serious questions about whether she will genuinely advance the agenda of transparency, individualized risk assessment, and a shift away from pharmaceutical-centric approaches or simply maintain the status quo under a new administration. The article contends that the central and only question that matters is whether Dr. Schwartz has undergone a fundamental change in perspective — whether she now recognizes the profound failures and harms of the pandemic response, the suppression of dissenting science, the overreach of mandates, and the need to prioritize root-cause prevention, nutrition, and environmental factors over perpetual vaccination and symptom management — or whether her appointment represents continuity rather than the transformative reform promised by MAHA. It acknowledges that Schwartz has administrative and military experience that could be valuable for managing a large bureaucracy, but insists that technical competence is insufficient if she remains aligned with the old paradigm that treated healthy populations as vectors to be controlled rather than individuals with the right to informed consent and personalized medicine. The piece examines her public record, noting that while she has not been as vocal a defender of mandates as some officials, her previous roles involved implementing federal policies that included vaccine requirements for service members and employees, raising legitimate doubts about her willingness to challenge entrenched institutional thinking at the CDC. The author urges the MAHA community and the administration to demand clear, specific answers on key issues: her stance on the childhood vaccine schedule, vaccine injury compensation reform, conflicts of interest in advisory committees, the role of nutrition and toxins in chronic disease, and her commitment to ending the one-size-fits-all approach that has contributed to declining public trust. The article warns that without a demonstrated shift in worldview and a willingness to confront the failures of the past, any appointment risks becoming another example of “same people, different titles,” undermining the momentum for real change. It concludes that the only question that ultimately matters is whether Dr. Schwartz is prepared to lead the CDC in a direction that prioritizes truth, transparency, and health restoration over institutional protection and pharmaceutical dependence.
Democrats Bend Over Backwards to Protect Big Pharma From RFK Jr.’s Reforms Democratic lawmakers and public health officials are mounting aggressive opposition to Health and Human Services Secretary Robert F. Kennedy Jr.’s efforts to reform federal vaccine policy, scrutinize pharmaceutical influence, and shift the focus of public health toward chronic disease prevention and root-cause solutions, with actions ranging from lawsuits by the American Academy of Pediatrics to legislative attempts to insulate states from federal changes and public statements framing Kennedy’s agenda as a threat to public health. The article highlights how Democrats have criticized Kennedy’s reconstitution of the Advisory Committee on Immunization Practices (ACIP), his emphasis on vaccine safety transparency, and his broader Make America Healthy Again (MAHA) initiatives as dangerous or ideologically driven, while simultaneously defending the existing vaccine schedule and pharmaceutical-centric model despite growing public skepticism and documented safety concerns. Specific examples include efforts to block Kennedy’s appointees, maintain universal vaccine recommendations, and prevent states from adopting more flexible or individualized policies, with some blue states moving to decouple their laws from federal ACIP guidance to preserve the status quo. Critics within the piece argue that this resistance reveals a prioritization of institutional and industry interests over genuine scientific debate, informed consent, and addressing the chronic disease epidemic affecting half of American children. The article contrasts this with Kennedy’s stated goals of increasing transparency around vaccine injuries, reevaluating the cumulative childhood schedule, reducing conflicts of interest, and redirecting resources toward nutrition, environmental toxin reduction, and lifestyle medicine. It frames the Democratic pushback as part of a broader pattern of protecting the pharmaceutical status quo, even as evidence of declining public trust, rising chronic conditions, and calls for accountability continue to mount. The piece calls for greater public awareness and support for reforms that prioritize patient autonomy, rigorous safety data, and prevention over mandates and perpetual medication.Hour 2
Why We Must Listen to the Vaccine-Injured The voices of the vaccine-injured must be heard and taken seriously if we are ever to restore trust in public health institutions and move toward genuine informed consent, because dismissing or gaslighting those who have suffered severe adverse reactions after vaccination — including myocarditis, neurological damage, autoimmune disorders, and death — not only inflicts further harm on the victims and their families but also prevents society from learning critical lessons about vaccine safety, the limitations of population-level policies, and the ethical necessity of individualized risk assessment. The article argues that the systematic marginalization of vaccine injury reports during and after the COVID-19 rollout, through mechanisms such as underreporting in VAERS, denial by medical professionals, censorship on social media, and the framing of any concern as “misinformation,” has created a profound betrayal of those who complied with mandates or recommendations in good faith. It emphasizes that true public health cannot be built on the suppression of harm; instead, it requires transparent acknowledgment of injuries, rigorous investigation of safety signals, removal of liability shields that reduce incentives for manufacturers to improve safety, and compensation systems that actually deliver timely and adequate support. The piece highlights the human cost — lost careers, lifelong disabilities, shattered families, and preventable deaths — and warns that ignoring these stories perpetuates a dangerous cycle where policy is driven by ideology or institutional protection rather than evidence and compassion. Listening to the injured means incorporating their experiences into risk-benefit analyses, protecting medical dissent, reforming advisory committees to reduce conflicts of interest, and shifting from one-size-fits-all mandates to personalized medicine that respects bodily autonomy and parental rights. The article ties this imperative directly to the Make America Healthy Again (MAHA) agenda, arguing that real reform begins with honesty about what has gone wrong, including the lack of long-term placebo-controlled trials for the cumulative childhood schedule and the understudied effects of repeated mRNA platforms. It calls on policymakers, journalists, and the public to reject the false dichotomy of “pro-vaccine” versus “anti-vaccine” and instead demand a mature, evidence-based conversation that centers the harmed, prioritizes prevention, and rebuilds trust through transparency rather than coercion. Ultimately, the piece asserts that a society that silences the vaccine-injured cannot claim to value science, ethics, or the common good.
Special Guest Sylvie Beljanski
Sylvie Beljanski is a prominent health advocate, author, and entrepreneur, dedicated to advancing holistic medicine and natural cancer solutions. As Vice President of The Beljanski Foundation, she continues the legacy of her father, Dr. Mirko Beljanski, by promoting research into natural cancer treatments. She is also CEO of Maison Beljanski, an international dietary supplement company, and an award-winning author of Winning The War On Cancer: The Epic Journey Towards a Natural Cure, a book recognized for its impact in holistic health and translated into French as Gagner La Lutte Contre Le Cancer.
With a background in law from The Sorbonne and a drive to bring science and nature together, Ms. Beljanski has made significant strides in the health and wellness industry. In 1996, she founded Natural Source International, Ltd., which creates natural health and beauty products, used worldwide. She opened Maison Beljanski in Manhattan in 2018 as a hub for health-focused events and resources, including her “Healthy Tuesdays” series, which gathers health professionals to share innovative holistic practices. The event series now also operates in France as “Les Jeudis de la Santé.”
Winning The War On Cancer has earned several prestigious awards in health and alternative medicine, including the Big Book Award, American Book Festival, and Independent Press Award. The book’s success as a bestseller has furthered Beljanski’s mission, with features in Hudson News locations and Barnes & Noble’s flagship store, bringing her insights on natural wellness and detoxification to a wider audience eager for alternative health solutions.




